SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SynAct Pharma partners with Hipolabor on dengue drug in Brazil

SynAct Pharma has partnered with Hipolabor to develop and commercialize resomelagon for dengue in Brazil.

Related stories